“Electric bikes tend to be more expensive than conventional bicycles, so most people will probably want a good all-arounder,” says Rich Handel, the engineer who leads CR’s electric bike ...

Electric bikes let you ride further and with less effort, yet also provide an exhausting workout if you choose. To find the best electric bikes on the market, I evaluated 12 popular bikes over ...

Offers from our trusted partners on this car and its predecessors ...

其车身尺寸超过5米，实际驾驶起来很像一辆传统的大型GT车型，这类车不以性能取胜，但能给人一种轻松惬意的感觉。 再有一个行业痛点就是增程器 ...

Last of the V8-powered muscle cars Full redesign includes new styling inside and out GT model remains V8 entry option More rear seat and trunk space This new generation for the Mustang means ...

The ‘ND’ Mazda MX-5 has been updated for its 10th birthday with sharper handling and much-needed tech improvements. Here’s why the lightest, most focused soft-top variant might be the one to ...

Realme is teasing the design and colour options of Realme GT 7 Pro It will be the first handset in India to run on Snapdragon 8 Elite SoC Realme UI 6.0 will launch along with the Realme GT 7 Pro ...

As a runner, I used to negatively associate stationary bikes with either bad weather or being injured. But as I started to shed my preconceived notions and the more I started to use them for ...

New York–based No. 22 Bicycles launched the Drifter X as a racier version of the Drifter model, with more flexibility to go further and faster on choppier terrain. Tire clearance between 28mm ...

Roche has inked a new deal with Dyno Ther­a­peu­tics to de­vel­op next-gen­er­a­tion AAV cap­sids for gene ther­a­pies tar­get­ing neu­ro­log­i­cal dis­eases, ex­pand­ing the ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases ...